FNY Managed Accounts’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
RG
PAI
FNY Managed Accounts's FOLD Position: Q2 2017 in Review
FNY Managed Accounts sold out of Amicus Therapeutics (FOLD) in Q2 2017, closing a stake of 180 shares — an estimated $1K sold.
FNY Managed Accounts first reported a position in FOLD in Q3 2016 and held it in 2 quarters. The position peaked at $37K in Q3 2016. 141 funds tracked by Wall St. Rank hold FOLD as of Q2 2017.
- FNY Managed Accounts reported no remaining Amicus Therapeutics position as of Q2 2017 after selling out during the quarter.
- FNY Managed Accounts sold 180 Amicus Therapeutics shares in Q2 2017, an estimated $1K.
- FNY Managed Accounts first reported a position in Amicus Therapeutics in Q3 2016 and held it in 2 quarters.
- FNY Managed Accounts's Amicus Therapeutics position peaked at $37K in Q3 2016.
- 141 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2017.
Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.